Publications by authors named "Destiny Schriefer"

Claim this Profile
C
Corrigendum to "A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults" [Drug Alcohol Depend. 272 (2025) 112676].
C Austin Zamarripa, Tory R Spindle, Destiny Schriefer, Edward J Cone, Ruth E Winecker

Drug Alcohol Depend· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults.
C Austin Zamarripa, Tory R Spindle, Destiny Schriefer, Edward J Cone, Ruth E Winecker

Drug Alcohol Depend· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A within-subject cross-over trial comparing the acute effects of vaporized delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults.
Tory R Spindle, C Austin Zamarripa, Destiny Schriefer, Edward J Cone, Ruth Winecker

Drug Alcohol Depend· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kratom use as more than a "self-treatment".
Kirsten E Smith, Kelly E Dunn, Jeffrey M Rogers, Oliver Grundmann, Christopher R McCurdy, Destiny Schriefer

Am J Drug Alcohol Abuse· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic.
Jeffrey M Rogers, Kirsten E Smith, Destiny Schriefer, David H Epstein

Subst Abuse· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Need for clarity and context in case reports on kratom use, assessment, and intervention.
Kirsten E Smith, Kelly E Dunn, David H Epstein, Jeffrey D Feldman, Albert Garcia-Romeu, Destiny Schriefer

Subst Abus· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change.
Albert J Burgess-Hull, Kirsten E Smith, Leigh V Panlilio, Destiny Schriefer, Kenzie L Preston

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories.
Kirsten E Smith, Jeffrey M Rogers, Kelly E Dunn, Oliver Grundmann, Christopher R McCurdy, Destiny Schriefer

Front Pharmacol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use.
Kirsten E Smith, Jeffrey M Rogers, Destiny Schriefer, Oliver Grundmann

Drug Alcohol Depend· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients.
Albert J Burgess-Hull, Kirsten E Smith, Destiny Schriefer, Leigh V Panlilio, David H Epstein

Drug Alcohol Depend· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.
Antonella Mangraviti, Tula Raghavan, Francesco Volpin, Nicolas Skuli, David Gullotti, Destiny Schriefer

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis